表紙：クラミジア・トラコマティス/淋菌（CT/NG）検査の世界市場規模、シェア、産業動向分析レポート：製品別、エンドユーザー別、検査タイプ別、技術別、地域別展望、2023年～2030年予測

市場調査レポート

商品コード

1335873

クラミジア・トラコマティス/淋菌（CT/NG）検査の世界市場規模、シェア、産業動向分析レポート：製品別、エンドユーザー別、検査タイプ別、技術別、地域別展望、2023年～2030年予測

Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Testing Type, By Technology, By Regional Outlook and Forecast, 2023 - 2030

出版日: 2023年07月31日 | 発行: KBV Research

| ページ情報: 英文 295 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 3,600 564,336円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 4,320 677,203円

レポートPDFを同一企業内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprisewide License)

USD 6,048 948,084円

レポートPDFを同一企業のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

クラミジア・トラコマティス/淋菌（CT/NG）検査市場規模は2030年までに28億米ドルに達すると予測され、予測期間中のCAGRは8.4%の市場成長率で上昇します。

しかし、必要な試薬、ツール、ベンダーによるセットアップなどの変動費が全体のコストを引き上げています。さらに、維持費や保険料、検査室の監督費、管理費（オフィススペース、賃貸料、管理費など）もかかります。膨大な数の診断ツールは、相当な資本予算のある大規模施設やレファレンスラボにしか手の届かないものかもしれないです。一方、小規模の検査室、診療所、独立開業医や個人開業医は、資本の制約から大型の装置や分析装置を購入することが難しいかもしれないです。このような高価な制約は市場拡大の妨げになるかもしれないです。市場の状況や価格は変化する可能性が高く、それが市場を押し下げる主な要因にもなっているため、現在の情報源を確認することは極めて重要です。

さらに、パンデミックの発生は当初、市場にマイナスの影響を与えました。検査機関がCT/NG検査を拒否したため、報告されない事例が増え、これらの疾患の蔓延が増加しました。検診の減少、限られた資源、政府による社会的疎外措置はすべて、この衰退に不可欠な役割を果たしました。

製品の展望

製品別では、市場はアッセイ＆キット、機器／分析器に区分されます。2022年の市場では、機器・分析装置部門が顕著な収益シェアを記録しました。このような疾患を診断するために、様々な機器や分析装置が市場で販売されました。それ以来、市場の継続的な進化により、新しい技術が進化している可能性があります。核酸増幅検査（NAAT）、自動分析装置などは、CT/NG検査によく使用される機器や分析装置です。クラミジア・トラコマティス/淋菌（CT/NG）検査に機器や分析装置を使用することで、これらの疾患の正確かつ迅速な検出に役立つ多くの重要な利点が得られます。

技術展望

技術ベースでは、市場は等温核酸増幅技術、ポリメラーゼ連鎖反応、免疫診断、その他の技術に細分化されます。2022年には、等温核酸増幅技術分野が市場で最も高い収益シェアを記録しました。迅速で正確な診断に対する需要の高まりと献血・輸血件数の増加が、INAAT分野の成長に寄与しています。その他の要因としては、CT/NGの普及率の上昇、INAATのコスト優位性、INAATのターンアラウンドタイム、これらの必要性が挙げられます。CT/NG診断におけるINAAT分野の高い感度と特異性は、同分野の成長の原因と言えます。

検査タイプの展望

検査タイプによって、市場はラボ検査とPoC検査に分類されます。PoC検査セグメントは2022年の市場で大きな収益シェアを獲得しました。PoC検査は、「ニアペイシェント検査」、「リモート検査」、「サテライト検査」、「迅速診断」など、数多くの用語で表現されます。ケアや治療が提供される場所、その近く、あるいはその場所で実施される検査はすべて、ポイントオブケア検査という広いカテゴリーに入る。この業界は、患者の嗜好の高まりと、ポイントオブケア診断薬の開発に対するメーカーの関心の高まりにより成長を遂げました。

エンドユーザーの展望

エンドユーザー別では、診断ラボ、病院、その他のエンドユーザーに分類されます。2022年には、診断ラボ部門が市場で最大の売上シェアを占める。これらの検査室は、クラミジア・トラコマティス／ナイセリア・ゴンロー（CT/NG）検査を用いてCT/NGを特定または診断し、最適な治療法を特定します。尿サンプルを採取し、CT/NG関連疾患の検査を行う。この分野の市場は、診断に熟練した専門家の存在と、こうした検査施設における最先端技術の利用可能性により拡大しています。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。2022年には、北米地域が市場で最も高い収益シェアを獲得しました。北米は主に、診断分野における技術開発をリードしてきました。この地域には研究開発のための強力なインフラがあり、これが最先端のプラットフォームや検査技術の採用を加速させています。市場においても、北米はいくつかの重要な企業の本拠地となっています。この地域の市場支配力は、これらの企業の豊富な経験、リソース、確立された販売網に起因しています。

北米
- 北米の市場：国別
  - 米国
  - カナダ
  - メキシコ
  - その他北米地域
欧州
- 欧州の市場：国別
  - ドイツ
  - 英国
  - フランス
  - ロシア
  - スペイン
  - イタリア
  - その他欧州地域
アジア太平洋
- アジア太平洋の市場：国別
  - 中国
  - 日本
  - インド
  - 韓国
  - シンガポール
  - マレーシア
  - その他アジア太平洋地域
ラテンアメリカ・中東・アフリカ
- ラテンアメリカ・中東・アフリカの市場：国別
  - ブラジル
  - アルゼンチン
  - アラブ首長国連邦
  - サウジアラビア
  - 南アフリカ
  - ナイジェリア
  - その他ラテンアメリカ・中東・アフリカ地域

第9章企業プロファイル

Abbott Laboratories
Becton, Dickinson, and Company
ZeptoMetrix LLC（Antylia Scientific）
Danaher Corporation
F Hoffmann-La Roche Ltd.
Hologic, Inc
Thermo Fisher Scientific, Inc
Bayer AG
Qiagen NV
Siemens AG

第10章クラミジア・トラコマチス/淋菌（CTNG）検査市場における勝利の必須条件

図表

LIST OF TABLES

TABLE 1 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 2 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 3 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 4 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 5 Global Assays & Kits Market by Region, 2019 - 2022, USD Million
TABLE 6 Global Assays & Kits Market by Region, 2023 - 2030, USD Million
TABLE 7 Global Instruments & Analyzers Market by Region, 2019 - 2022, USD Million
TABLE 8 Global Instruments & Analyzers Market by Region, 2023 - 2030, USD Million
TABLE 9 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 10 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 11 Global Diagnostic Laboratories Market by Region, 2019 - 2022, USD Million
TABLE 12 Global Diagnostic Laboratories Market by Region, 2023 - 2030, USD Million
TABLE 13 Global Hospitals & Clinics Market by Region, 2019 - 2022, USD Million
TABLE 14 Global Hospitals & Clinics Market by Region, 2023 - 2030, USD Million
TABLE 15 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 16 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 17 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 18 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 19 Global Lab Tests Market by Region, 2019 - 2022, USD Million
TABLE 20 Global Lab Tests Market by Region, 2023 - 2030, USD Million
TABLE 21 Global PoC Tests Market by Region, 2019 - 2022, USD Million
TABLE 22 Global PoC Tests Market by Region, 2023 - 2030, USD Million
TABLE 23 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 24 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 25 Global Isothermal Nucleic Acid Amplification Technology Market by Region, 2019 - 2022, USD Million
TABLE 26 Global Isothermal Nucleic Acid Amplification Technology Market by Region, 2023 - 2030, USD Million
TABLE 27 Global Polymerase Chain Reaction Market by Region, 2019 - 2022, USD Million
TABLE 28 Global Polymerase Chain Reaction Market by Region, 2023 - 2030, USD Million
TABLE 29 Global Immunodiagnostics Market by Region, 2019 - 2022, USD Million
TABLE 30 Global Immunodiagnostics Market by Region, 2023 - 2030, USD Million
TABLE 31 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 32 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 33 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Region, 2019 - 2022, USD Million
TABLE 34 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Region, 2023 - 2030, USD Million
TABLE 35 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 36 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 37 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 38 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 39 North America Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 41 North America Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 43 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 44 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 45 North America Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 46 North America Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 47 North America Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
TABLE 48 North America Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
TABLE 49 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 50 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 51 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 52 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 53 North America Lab Tests Market by Country, 2019 - 2022, USD Million
TABLE 54 North America Lab Tests Market by Country, 2023 - 2030, USD Million
TABLE 55 North America PoC Tests Market by Country, 2019 - 2022, USD Million
TABLE 56 North America PoC Tests Market by Country, 2023 - 2030, USD Million
TABLE 57 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 58 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 59 North America Isothermal Nucleic Acid Amplification Technology Market by Country, 2019 - 2022, USD Million
TABLE 60 North America Isothermal Nucleic Acid Amplification Technology Market by Country, 2023 - 2030, USD Million
TABLE 61 North America Polymerase Chain Reaction Market by Country, 2019 - 2022, USD Million
TABLE 62 North America Polymerase Chain Reaction Market by Country, 2023 - 2030, USD Million
TABLE 63 North America Immunodiagnostics Market by Country, 2019 - 2022, USD Million
TABLE 64 North America Immunodiagnostics Market by Country, 2023 - 2030, USD Million
TABLE 65 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 66 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 67 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2019 - 2022, USD Million
TABLE 68 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2023 - 2030, USD Million
TABLE 69 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 70 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 71 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 72 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 73 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 74 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 75 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 76 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 77 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 78 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 79 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 80 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 81 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 82 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 83 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 84 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 85 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 86 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 87 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 88 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 89 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 90 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 91 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 92 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 93 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 94 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 95 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 96 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 97 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 98 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 99 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 100 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 101 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 102 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 103 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 104 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 105 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 106 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 107 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 108 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 109 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 110 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 111 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 112 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 113 Europe Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 114 Europe Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 115 Europe Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 116 Europe Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 117 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 118 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 119 Europe Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 120 Europe Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 121 Europe Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
TABLE 122 Europe Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
TABLE 123 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 124 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 125 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 126 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 127 Europe Lab Tests Market by Country, 2019 - 2022, USD Million
TABLE 128 Europe Lab Tests Market by Country, 2023 - 2030, USD Million
TABLE 129 Europe PoC Tests Market by Country, 2019 - 2022, USD Million
TABLE 130 Europe PoC Tests Market by Country, 2023 - 2030, USD Million
TABLE 131 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 132 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 133 Europe Isothermal Nucleic Acid Amplification Technology Market by Country, 2019 - 2022, USD Million
TABLE 134 Europe Isothermal Nucleic Acid Amplification Technology Market by Country, 2023 - 2030, USD Million
TABLE 135 Europe Polymerase Chain Reaction Market by Country, 2019 - 2022, USD Million
TABLE 136 Europe Polymerase Chain Reaction Market by Country, 2023 - 2030, USD Million
TABLE 137 Europe Immunodiagnostics Market by Country, 2019 - 2022, USD Million
TABLE 138 Europe Immunodiagnostics Market by Country, 2023 - 2030, USD Million
TABLE 139 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 140 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 141 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2019 - 2022, USD Million
TABLE 142 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2023 - 2030, USD Million
TABLE 143 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 144 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 145 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 146 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 147 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 148 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 149 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 150 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 151 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 152 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 153 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 154 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 155 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 156 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 157 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 158 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 159 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 160 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 161 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 162 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 163 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 164 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 165 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 166 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 167 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 168 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 169 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 170 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 171 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 172 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 173 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 174 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 175 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 176 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 177 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 178 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 179 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 180 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 181 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 182 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 183 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 184 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 185 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 186 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 187 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 188 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 189 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 190 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 191 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 192 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 193 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 194 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 195 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 196 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 197 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 198 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 199 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 200 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 201 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 202 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 203 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 204 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 205 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 206 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 207 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 208 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 209 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 210 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 211 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 212 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 213 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 214 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 215 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 216 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 217 Asia Pacific Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 218 Asia Pacific Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 219 Asia Pacific Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 220 Asia Pacific Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 221 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 222 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 223 Asia Pacific Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 224 Asia Pacific Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 225 Asia Pacific Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
TABLE 226 Asia Pacific Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
TABLE 227 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 228 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 229 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 230 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 231 Asia Pacific Lab Tests Market by Country, 2019 - 2022, USD Million
TABLE 232 Asia Pacific Lab Tests Market by Country, 2023 - 2030, USD Million
TABLE 233 Asia Pacific PoC Tests Market by Country, 2019 - 2022, USD Million
TABLE 234 Asia Pacific PoC Tests Market by Country, 2023 - 2030, USD Million
TABLE 235 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 236 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 237 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by Country, 2019 - 2022, USD Million
TABLE 238 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by Country, 2023 - 2030, USD Million
TABLE 239 Asia Pacific Polymerase Chain Reaction Market by Country, 2019 - 2022, USD Million
TABLE 240 Asia Pacific Polymerase Chain Reaction Market by Country, 2023 - 2030, USD Million
TABLE 241 Asia Pacific Immunodiagnostics Market by Country, 2019 - 2022, USD Million
TABLE 242 Asia Pacific Immunodiagnostics Market by Country, 2023 - 2030, USD Million
TABLE 243 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 244 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 245 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2019 - 2022, USD Million
TABLE 246 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2023 - 2030, USD Million
TABLE 247 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 248 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 249 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 250 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 251 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 252 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 253 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 254 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 255 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 256 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 257 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 258 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 259 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 260 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 261 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 262 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 263 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 264 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 265 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 266 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 267 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 268 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 269 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 270 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 271 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 272 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 273 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 274 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 275 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 276 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 277 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 278 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 279 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 280 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 281 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 282 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 283 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 284 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 285 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 286 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 287 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 288 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 289 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 290 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 291 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 292 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 293 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 294 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 295 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 296 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 297 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 298 Malaysia Chlamydi

TABLE 317 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 318 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 319 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 320 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 321 LAMEA Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 322 LAMEA Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 323 LAMEA Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 324 LAMEA Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 325 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 326 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 327 LAMEA Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 328 LAMEA Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 329 LAMEA Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
TABLE 330 LAMEA Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
TABLE 331 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 332 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 333 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 334 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 335 LAMEA Lab Tests Market by Country, 2019 - 2022, USD Million
TABLE 336 LAMEA Lab Tests Market by Country, 2023 - 2030, USD Million
TABLE 337 LAMEA PoC Tests Market by Country, 2019 - 2022, USD Million
TABLE 338 LAMEA PoC Tests Market by Country, 2023 - 2030, USD Million
TABLE 339 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 340 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 341 LAMEA Isothermal Nucleic Acid Amplification Technology Market by Country, 2019 - 2022, USD Million
TABLE 342 LAMEA Isothermal Nucleic Acid Amplification Technology Market by Country, 2023 - 2030, USD Million
TABLE 343 LAMEA Polymerase Chain Reaction Market by Country, 2019 - 2022, USD Million
TABLE 344 LAMEA Polymerase Chain Reaction Market by Country, 2023 - 2030, USD Million
TABLE 345 LAMEA Immunodiagnostics Market by Country, 2019 - 2022, USD Million
TABLE 346 LAMEA Immunodiagnostics Market by Country, 2023 - 2030, USD Million
TABLE 347 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 348 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 349 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2019 - 2022, USD Million
TABLE 350 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2023 - 2030, USD Million
TABLE 351 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 352 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 353 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 354 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 355 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 356 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 357 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 358 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 359 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 360 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 361 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 362 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 363 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 364 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 365 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 366 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 367 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 368 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 369 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 370 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 371 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 372 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 373 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 374 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 375 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 376 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 377 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 378 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 379 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 380 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 381 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 382 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 383 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 384 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 385 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 386 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 387 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 388 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 389 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 390 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 391 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 392 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 393 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 394 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 395 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 396 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 397 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 398 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 399 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 400 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 401 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 402 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 403 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 404 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 405 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 406 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 407 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 408 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 409 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 410 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 411 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 412 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 413 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 414 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 415 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 416 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 417 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 418 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 419 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 420 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 421 Key Information - Abbott Laboratories
TABLE 422 Key information - Becton, Dickinson and Company
TABLE 423 Key Information - ZeptoMetrix LLC
TABLE 424 Key Information - Danaher Corporation
TABLE 425 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 426 Key Information - Hologic, Inc.
TABLE 427 Key Information - Thermo Fisher Scientific, Inc.
TABLE 428 Key Information - Bayer AG
TABLE 429 Key Information - Qiagen N.V.
TABLE 430 Key Information - Siemens AG

List of Figures

FIG 1 Methodology for the research
FIG 2 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2030, USD Million
FIG 3 Key Impacting Factors chlamydia trachomatis/neisseria gonorrhoeae (CT/NG) testing market
FIG 4 Porter's Five Forces Analysis - Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
FIG 5 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Product, 2022
FIG 6 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Product, 2030
FIG 7 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2030, USD Million
FIG 8 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by End User, 2022
FIG 9 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by End User, 2030
FIG 10 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2030, USD Million
FIG 11 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Testing Type, 2022
FIG 12 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Testing Type, 2030
FIG 13 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2030, USD Million
FIG 14 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Technology, 2022
FIG 15 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Technology, 2030
FIG 16 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2030, USD Million
FIG 17 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Region, 2022
FIG 18 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Region, 2030
FIG 19 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Region, 2019 - 2030, USD Million
FIG 20 SWOT Analysis: Abbott Laboratories
FIG 21 SWOT Analysis: Becton, Dickinson and company
FIG 22 SWOT Analysis: Becton, Dickinson and company
FIG 23 SWOT Analysis: Danaher Corporation
FIG 24 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 25 Swot Analysis: Hologic, Inc.
FIG 26 Swot Analysis: Thermo Fisher Scientific, Inc.
FIG 27 Swot Analysis: Bayer AG
FIG 28 Swot Analysis: Qiagen N.V.
FIG 29 SWOT Analysis: Siemens AG

The Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market size is expected to reach $2.8 billion by 2030, rising at a market growth of 8.4% CAGR during the forecast period.

Asia Pacific's emerging nations have seen increases in their GDPs and levels of disposable income. These developments have led to higher healthcare expenditures, modernized healthcare infrastructure, and a growing uptake of clinical laboratory technologies in Asia Pacific nations. Consequently, the Asia Pacific region would acquire approximately 2/5th share of the market by 2030. Low regulatory obstacles, improved healthcare infrastructure, an escalating patient population, an increase in infections, and rising healthcare costs are all possible causes. Additionally, compared to wealthy countries, several of these nations' regulatory systems are more flexible and business friendly. Some of the factors impacting the market are increasing funds and investments, high instances of sexually transmitted diseases (STDs) and sexually transmitted infections (STIs), and the high price of instruments.

The market has growth potential due to government programs, funding initiatives, and other initiatives supporting and promoting innovation and development. Companies might invest in infrastructure, improved diagnostic technology production, research and development, financial incentives, and support systems. By making it easier for manufacturers to get funding, they are motivated to advance CT/NG testing, resulting in ground-breaking developments in disease detection, monitoring, and specialty medicine. It is anticipated that more developing nations would have access to high-quality healthcare as a result of their rapid economic growth and rising healthcare costs. This is seen as an indication that the market is expanding. The frequency of sexually transmitted infections (STIs) is increasing globally, which will be a key factor in the market's growth rate. According to estimates from the World Health Organization (WHO), more than 1 million asymptomatic STIs are contracted each day worldwide. In 2020, an estimated 374 million new cases of one of the four STIs (gonorrhoea (82 million), chlamydia (129 million), syphilis (7.1 million), or trichomoniasis (156 million)) will be reported. Abdominal pain, urethral discharge or burning in males, genital ulcers, and vaginal discharge are all typical STI symptoms. As a result, the market is expected to expand due to the increased prevalence of STIs.

However, the variable costs of the necessary reagents, tools, and setup by the vendors raise the overall cost. Additional expenses include maintenance and insurance, laboratory supervision, and administrative costs (which include office space, rent, and administration). The vast array of diagnostic tools may only be affordable to large institutions and reference labs with substantial capital budgets. On the other hand, small laboratories, medical practices, and independent or private practitioners may have trouble affording large or bulky devices and analyzers due to capital constraints. These expensive constraints may hamper the market expansion. It is crucial to check current sources because market conditions and pricing are likely to change, which is also a key factor driving the market down.

Furthermore, the pandemic outbreak initially had a negative impact on the market. Due to the laboratories' denial of the CT/NG tests, more instances were not reported, and there was an increase in the spread of these diseases. Reduced screening, limited resources, and social alienation measures established by the government all contributed an essential role in this decline.

Product Outlook

On the basis of product, the market is segmented into assays & kits, instruments/analyzers. The instruments/analyzers segment recorded a remarkable revenue share in the market in 2022. To diagnose such diseases, various instruments and analyzers were sold in the market. Since then, new technologies might have evolved due to the market's ongoing evolution. Nucleic Acid Amplification Tests (NAATs), Automated Analyzers, etc., are some instruments and analyzers often used for CT/NG testing. Using instruments and analyzers in Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) testing provides many significant benefits that help in the accurate and speedy detection of these diseases.

Technology Outlook

On the basis of technology, the market is fragmented into isothermal nucleic acid amplification technology, polymerase chain reaction, immunodiagnostics, and other technologies. In 2022, the isothermal nucleic acid amplification technology segment registered the highest revenue share in the market. The growing demand for quick, accurate diagnoses and the rising number of blood donations and transfusions have contributed to the growth of the INAAT sector. Other factors are the rising prevalence of CT/NG, the cost advantages of INAAT, the turnaround time of INAAT, and the necessity for these things. The INAAT segment's high sensitivity and specificity in CT/NG diagnosis can be blamed for segment's growth.

Testing Type Outlook

Based on testing type, the market is classified into lab tests, and PoC tests. The PoC tests segment garnered a significant revenue share in the market in 2022. Numerous terms, including "near-patient testing," "remote testing," "satellite testing," and "rapid diagnostics," may be used to describe it. Any test carried out at, close to, or at the location where care or treatment is provided falls within the broad category of point-of-care testing. This industry experienced growth due to patients' rising preferences and manufacturers' rising attention to creating point-of-care diagnostics.

End User Outlook

By end user, the market categorised into diagnostic laboratories, hospital & clinics, and other end users. In 2022, the diagnostic laboratories segment witnessed the largest revenue share in the market. These laboratories use chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) testing to identify or diagnose CT/NG and identify the best therapies. They take urine samples which are examined for CT/NG related diseases. The market is growing in this segment as a result of the presence of highly skilled professionals for diagnostics and availability of cutting-edge technologies in such laboratories.

Regional Outlook

Region wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region generated the highest revenue share in the market. North America primarily led the development of technology in the region of diagnostics. A strong infrastructure for research and development is found in this region, which has accelerated the adoption of cutting-edge platforms and testing techniques. In the market, North America is also home to several significant businesses. The region's market dominance can be attributed to these businesses' extensive experience, resources, and established distribution networks.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, ZeptoMetrix LLC (Antylia Scientific), Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc., Thermo Fisher Scientific, Inc., Bayer AG, Qiagen N.V. and Siemens AG.

Scope of the Study

Market Segments covered in the Report:

By Product

Assays & Kits
Instruments & Analyzers

By End User

Diagnostic Laboratories
Hospitals & Clinics
Others

By Testing Type

Lab Tests
PoC Tests

By Technology

Isothermal Nucleic Acid Amplification Technology
Polymerase Chain Reaction
Immunodiagnostics
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Companies Profiled

Abbott Laboratories
Becton, Dickinson and Company
ZeptoMetrix LLC (Antylia Scientific)
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
Thermo Fisher Scientific, Inc.
Bayer AG
Qiagen N.V.
Siemens AG

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Product
- 1.4.2 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by End User
- 1.4.3 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Testing Type
- 1.4.4 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Technology
- 1.4.5 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Geography
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter's Five Forces Analysis

Chapter 4. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product

4.1 Global Assays & Kits Market by Region
4.2 Global Instruments & Analyzers Market by Region

Chapter 5. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User

5.1 Global Diagnostic Laboratories Market by Region
5.2 Global Hospitals & Clinics Market by Region
5.3 Global Others Market by Region

Chapter 6. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type

6.1 Global Lab Tests Market by Region
6.2 Global PoC Tests Market by Region

Chapter 7. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology

7.1 Global Isothermal Nucleic Acid Amplification Technology Market by Region
7.2 Global Polymerase Chain Reaction Market by Region
7.3 Global Immunodiagnostics Market by Region
7.4 Global Others Market by Region

Chapter 8. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Region

8.1 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.1.1 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
  - 8.1.1.1 North America Assays & Kits Market by Country
  - 8.1.1.2 North America Instruments & Analyzers Market by Country
- 8.1.2 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
  - 8.1.2.1 North America Diagnostic Laboratories Market by Country
  - 8.1.2.2 North America Hospitals & Clinics Market by Country
  - 8.1.2.3 North America Others Market by Country
- 8.1.3 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
  - 8.1.3.1 North America Lab Tests Market by Country
  - 8.1.3.2 North America PoC Tests Market by Country
- 8.1.4 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.1.4.1 North America Isothermal Nucleic Acid Amplification Technology Market by Country
  - 8.1.4.2 North America Polymerase Chain Reaction Market by Country
  - 8.1.4.3 North America Immunodiagnostics Market by Country
  - 8.1.4.4 North America Others Market by Country
- 8.1.5 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country
  - 8.1.5.1 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.1.5.1.1 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.1.5.1.2 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.1.5.1.3 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.1.5.1.4 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.1.5.2 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.1.5.2.1 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.1.5.2.2 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.1.5.2.3 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.1.5.2.4 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.1.5.3 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.1.5.3.1 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.1.5.3.2 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.1.5.3.3 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.1.5.3.4 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.1.5.4 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.1.5.4.1 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.1.5.4.2 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.1.5.4.3 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.1.5.4.4 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
8.2 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.2.1 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
  - 8.2.1.1 Europe Assays & Kits Market by Country
  - 8.2.1.2 Europe Instruments & Analyzers Market by Country
- 8.2.2 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
  - 8.2.2.1 Europe Diagnostic Laboratories Market by Country
  - 8.2.2.2 Europe Hospitals & Clinics Market by Country
  - 8.2.2.3 Europe Others Market by Country
- 8.2.3 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
  - 8.2.3.1 Europe Lab Tests Market by Country
  - 8.2.3.2 Europe PoC Tests Market by Country
- 8.2.4 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.2.4.1 Europe Isothermal Nucleic Acid Amplification Technology Market by Country
  - 8.2.4.2 Europe Polymerase Chain Reaction Market by Country
  - 8.2.4.3 Europe Immunodiagnostics Market by Country
  - 8.2.4.4 Europe Others Market by Country
- 8.2.5 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country
  - 8.2.5.1 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.2.5.1.1 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.2.5.1.2 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.2.5.1.3 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.2.5.1.4 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.2.5.2 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.2.5.2.1 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.2.5.2.2 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.2.5.2.3 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.2.5.2.4 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.2.5.3 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.2.5.3.1 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.2.5.3.2 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.2.5.3.3 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.2.5.3.4 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.2.5.4 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.2.5.4.1 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.2.5.4.2 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.2.5.4.3 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.2.5.4.4 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.2.5.5 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.2.5.5.1 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.2.5.5.2 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.2.5.5.3 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.2.5.5.4 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.2.5.6 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.2.5.6.1 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.2.5.6.2 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.2.5.6.3 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.2.5.6.4 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.2.5.7 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.2.5.7.1 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.2.5.7.2 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.2.5.7.3 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.2.5.7.4 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
8.3 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.3.1 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
  - 8.3.1.1 Asia Pacific Assays & Kits Market by Country
  - 8.3.1.2 Asia Pacific Instruments & Analyzers Market by Country
- 8.3.2 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
  - 8.3.2.1 Asia Pacific Diagnostic Laboratories Market by Country
  - 8.3.2.2 Asia Pacific Hospitals & Clinics Market by Country
  - 8.3.2.3 Asia Pacific Others Market by Country
- 8.3.3 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
  - 8.3.3.1 Asia Pacific Lab Tests Market by Country
  - 8.3.3.2 Asia Pacific PoC Tests Market by Country
- 8.3.4 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.3.4.1 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by Country
  - 8.3.4.2 Asia Pacific Polymerase Chain Reaction Market by Country
  - 8.3.4.3 Asia Pacific Immunodiagnostics Market by Country
  - 8.3.4.4 Asia Pacific Others Market by Country
- 8.3.5 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country
  - 8.3.5.1 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.3.5.1.1 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.3.5.1.2 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.3.5.1.3 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.3.5.1.4 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.3.5.2 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.3.5.2.1 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.3.5.2.2 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.3.5.2.3 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.3.5.2.4 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.3.5.3 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.3.5.3.1 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.3.5.3.2 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.3.5.3.3 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.3.5.3.4 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.3.5.4 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.3.5.4.1 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.3.5.4.2 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.3.5.4.3 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.3.5.4.4 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.3.5.5 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.3.5.5.1 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.3.5.5.2 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.3.5.5.3 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.3.5.5.4 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.3.5.6 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.3.5.6.1 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.3.5.6.2 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.3.5.6.3 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.3.5.6.4 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.3.5.7 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.3.5.7.1 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.3.5.7.2 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.3.5.7.3 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.3.5.7.4 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
8.4 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.4.1 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
  - 8.4.1.1 LAMEA Assays & Kits Market by Country
  - 8.4.1.2 LAMEA Instruments & Analyzers Market by Country
- 8.4.2 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
  - 8.4.2.1 LAMEA Diagnostic Laboratories Market by Country
  - 8.4.2.2 LAMEA Hospitals & Clinics Market by Country
  - 8.4.2.3 LAMEA Others Market by Country
- 8.4.3 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
  - 8.4.3.1 LAMEA Lab Tests Market by Country
  - 8.4.3.2 LAMEA PoC Tests Market by Country
- 8.4.4 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.4.4.1 LAMEA Isothermal Nucleic Acid Amplification Technology Market by Country
  - 8.4.4.2 LAMEA Polymerase Chain Reaction Market by Country
  - 8.4.4.3 LAMEA Immunodiagnostics Market by Country
  - 8.4.4.4 LAMEA Others Market by Country
- 8.4.5 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country
  - 8.4.5.1 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.4.5.1.1 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.4.5.1.2 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.4.5.1.3 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.4.5.1.4 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.4.5.2 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.4.5.2.1 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.4.5.2.2 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.4.5.2.3 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.4.5.2.4 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.4.5.3 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.4.5.3.1 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.4.5.3.2 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.4.5.3.3 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.4.5.3.4 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.4.5.4 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.4.5.4.1 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.4.5.4.2 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.4.5.4.3 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.4.5.4.4 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.4.5.5 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.4.5.5.1 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.4.5.5.2 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.4.5.5.3 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.4.5.5.4 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.4.5.6 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.4.5.6.1 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.4.5.6.2 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.4.5.6.3 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.4.5.6.4 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.4.5.7 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.4.5.7.1 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.4.5.7.2 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.4.5.7.3 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.4.5.7.4 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology

Chapter 9. Company Profiles

9.1 Abbott Laboratories
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
  - 9.1.5.1 Trials & Approvals:
- 9.1.6 SWOT Analysis
9.2 Becton, Dickinson, and Company
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
  - 9.2.5.1 Product Launches and Product Expansions:
- 9.2.6 SWOT Analysis
9.3 ZeptoMetrix LLC (Antylia Scientific)
- 9.3.1 Company Overview
- 9.3.2 SWOT Analysis
9.4 Danaher Corporation
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 SWOT Analysis
9.5 F. Hoffmann-La Roche Ltd.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
  - 9.5.5.1 Trials & Approvals:
- 9.5.6 SWOT Analysis
9.6 Hologic, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 SWOT Analysis
9.7 Thermo Fisher Scientific, Inc.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
9.8 Bayer AG
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expense
- 9.8.5 SWOT Analysis
9.9 Qiagen N.V.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 SWOT Analysis
9.10. Siemens AG
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expense
- 9.10.5 SWOT Analysis

クラミジア・トラコマティス/淋菌（CT/NG）検査の世界市場規模、シェア、産業動向分析レポート：製品別、エンドユーザー別、検査タイプ別、技術別、地域別展望、2023年～2030年予測

Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Testing Type, By Technology, By Regional Outlook and Forecast, 2023 - 2030

目次

第1章市場範囲と調査手法

第2章市場の概要

第3章市場概要

第4章世界のクラミジア・トラコマチス/淋菌（CT/NG）検査市場：製品別

第5章世界のクラミジア・トラコマチス/淋菌（CT/NG）検査市場：エンドユーザー別

第6章世界のクラミジア・トラコマチス/淋菌（CT/NG）検査市場：テストの種類別

第7章世界のクラミジア・トラコマチス/淋菌（CT/NG）検査市場：技術別

第8章世界のクラミジア・トラコマチス/淋菌（CT/NG）検査市場：地域別

第9章企業プロファイル

第10章クラミジア・トラコマチス/淋菌（CTNG）検査市場における勝利の必須条件

LIST OF TABLES

Scope of the Study

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product

Chapter 5. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User

Chapter 6. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type

Chapter 7. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology

Chapter 8. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Region

Chapter 9. Company Profiles

Chapter 10. Winning Imperative for Chlamydia trachomatis/Neisseria gonorrhoeae (CTNG) Testing Market

クラミジア・トラコマティス/淋菌（CT/NG）検査の世界市場規模、シェア、産業動向分析レポート：製品別、エンドユーザー別、検査タイプ別、技術別、地域別展望、2023年～2030年予測

Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Testing Type, By Technology, By Regional Outlook and Forecast, 2023 - 2030

目次

第1章 市場範囲と調査手法

第2章 市場の概要

第3章 市場概要

第4章 世界のクラミジア・トラコマチス/淋菌（CT/NG）検査市場：製品別

第5章 世界のクラミジア・トラコマチス/淋菌（CT/NG）検査市場：エンドユーザー別

第6章 世界のクラミジア・トラコマチス/淋菌（CT/NG）検査市場：テストの種類別

第7章 世界のクラミジア・トラコマチス/淋菌（CT/NG）検査市場：技術別

第8章 世界のクラミジア・トラコマチス/淋菌（CT/NG）検査市場：地域別

第9章 企業プロファイル

第10章 クラミジア・トラコマチス/淋菌（CTNG）検査市場における勝利の必須条件

LIST OF TABLES

Scope of the Study

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product

Chapter 5. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User

Chapter 6. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type

Chapter 7. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology

Chapter 8. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Region

Chapter 9. Company Profiles

Chapter 10. Winning Imperative for Chlamydia trachomatis/Neisseria gonorrhoeae (CTNG) Testing Market

第1章市場範囲と調査手法

第2章市場の概要

第3章市場概要

第4章世界のクラミジア・トラコマチス/淋菌（CT/NG）検査市場：製品別

第5章世界のクラミジア・トラコマチス/淋菌（CT/NG）検査市場：エンドユーザー別

第6章世界のクラミジア・トラコマチス/淋菌（CT/NG）検査市場：テストの種類別

第7章世界のクラミジア・トラコマチス/淋菌（CT/NG）検査市場：技術別

第8章世界のクラミジア・トラコマチス/淋菌（CT/NG）検査市場：地域別

第9章企業プロファイル

第10章クラミジア・トラコマチス/淋菌（CTNG）検査市場における勝利の必須条件